DSGN Shares

Companies

How Do Analysts Perceive Design Therapeutics Inc (DSGN)?

Colin Adrian

Design Therapeutics Inc (DSGN) saw downtrend of -0.85% in the recent trading with $9.28 being its most recent. The current ...

Value Stocks

Design Therapeutics Inc (DSGN): The stock’s intermediate-term indicators point to Buy today

Colin Adrian

Design Therapeutics Inc (DSGN) saw an uptrend of 1.46% in the recent trading with $9.74 being its most recent. The ...

Baxter Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.